Patents by Inventor Fenneke G. Joslin

Fenneke G. Joslin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6858409
    Abstract: Compounds are disclosed having the general formula R1—X—R2, wherein R1 and R2 are biologically active groups, at least one of which is polypeptidic. X is a non-peptidic polymeric group. R1 and R2 may be the same or different. Preferred R1 and R2 groups are interleukin-1 receptor antagonist, 30 kDa TNF inhibitor, interleukin-2 receptors and CR1 and muteins thereof. Also included are site selectively modified interleukin-1 receptor antagonist and 30 kDa TNF inhibitor.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 22, 2005
    Assignees: Amgen Inc., The Regents of the University of Colorado
    Inventors: Robert C. Thompson, Charles H. Hannum, Stephen P. Eisenberg, William P. Arend, Fenneke G. Joslin, Andreas Sommer
  • Patent number: 6599873
    Abstract: Interleukin-1 inhibitors are provided. Compositions comprising an interleukin-1 inhibitor are provided. Methods of treating a patient comprising administering an interleukin-1 inhibitor are provided.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 29, 2003
    Assignees: Amgen Inc., The Regents of the University of Colorado
    Inventors: Andreas Sommer, Charles H. Hannum, Stephen P. Eisenburg, Robert C. Thompson, William P. Arend, Fenneke G. Joslin
  • Patent number: 5075222
    Abstract: DNA sequences that encode Interleukin-1 inhibitors and recombinant-DNA methods for the production of interleukin-1 inhibitors are provided. The DNA sequences encode proteins having interleukin-1 inhibitors activity.
    Type: Grant
    Filed: April 6, 1990
    Date of Patent: December 24, 1991
    Assignee: Synergen, Inc.
    Inventors: Charles H. Hannum, Stephen P. Eisenburg, Robert C. Thompson, William P. Arend, Fenneke G. Joslin